Ampersand wins £22m five-year contract at London Zoo
June 25, 2012
The Purpose Advantage: An Anchor for Sustainable Business Growth
January 5, 2025
The FINANCIAL -- Cambridge scientists have created a comprehensive tool for predicting an individual’s risk of developing prostate cancer, which ...
The FINANCIAL -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced that the China National ...